Thursday, 21 April 2022

Panel OKs Corbevax for 5-11 group; final nod ‘soon’

The drug regulator’s expert panel on Covid vaccines has recommended granting emergency use authorisation to Biological E’s Corbevax for use in children in the 5-11 years’ age group, official sources said on Thursday. The final approval to Corbevax by the Drugs Controller General of India (DCGI) is expected by next week. Via Times of India https://ift.tt/n0MGH9r

No comments:

Post a Comment